RS56746B1 - Imidazopirazinon derivati - Google Patents

Imidazopirazinon derivati

Info

Publication number
RS56746B1
RS56746B1 RS20171341A RSP20171341A RS56746B1 RS 56746 B1 RS56746 B1 RS 56746B1 RS 20171341 A RS20171341 A RS 20171341A RS P20171341 A RSP20171341 A RS P20171341A RS 56746 B1 RS56746 B1 RS 56746B1
Authority
RS
Serbia
Prior art keywords
imidazopyrazinone
derivatives
imidazopyrazinone derivatives
Prior art date
Application number
RS20171341A
Other languages
English (en)
Inventor
Hans-Peter Buchstaller
Dieter Dorsch
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of RS56746B1 publication Critical patent/RS56746B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/527Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim spiro-condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Lubricants (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
RS20171341A 2013-12-23 2014-12-03 Imidazopirazinon derivati RS56746B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13006052 2013-12-23
PCT/EP2014/003226 WO2015096884A1 (en) 2013-12-23 2014-12-03 Imidazopyrazinone derivatives
EP14808506.1A EP3087076B1 (en) 2013-12-23 2014-12-03 Imidazopyrazinone derivatives

Publications (1)

Publication Number Publication Date
RS56746B1 true RS56746B1 (sr) 2018-03-30

Family

ID=49916790

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20171341A RS56746B1 (sr) 2013-12-23 2014-12-03 Imidazopirazinon derivati

Country Status (23)

Country Link
US (1) US9718826B2 (sr)
EP (1) EP3087076B1 (sr)
JP (1) JP6446461B2 (sr)
KR (1) KR20160101188A (sr)
CN (1) CN105829317B (sr)
AU (1) AU2014372896B2 (sr)
CA (1) CA2934663A1 (sr)
DK (1) DK3087076T3 (sr)
ES (1) ES2654403T3 (sr)
HR (1) HRP20171783T1 (sr)
HU (1) HUE037606T2 (sr)
IL (1) IL246406A0 (sr)
LT (1) LT3087076T (sr)
MX (1) MX364859B (sr)
NO (1) NO3087076T3 (sr)
PL (1) PL3087076T3 (sr)
PT (1) PT3087076T (sr)
RS (1) RS56746B1 (sr)
RU (1) RU2672885C2 (sr)
SG (1) SG11201605189YA (sr)
SI (1) SI3087076T1 (sr)
TW (1) TWI637956B (sr)
WO (1) WO2015096884A1 (sr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017156350A1 (en) 2016-03-09 2017-09-14 K-Gen, Inc. Methods of cancer treatment
TWI794171B (zh) 2016-05-11 2023-03-01 美商滬亞生物國際有限公司 Hdac抑制劑與pd-l1抑制劑之組合治療
TWI808055B (zh) 2016-05-11 2023-07-11 美商滬亞生物國際有限公司 Hdac 抑制劑與 pd-1 抑制劑之組合治療
TW201822637A (zh) 2016-11-07 2018-07-01 德商拜耳廠股份有限公司 用於控制動物害蟲的經取代磺醯胺類
CN108403697A (zh) * 2018-05-02 2018-08-17 吉林大学 吡嗪酮类小分子抑制剂在制备抗肿瘤药物中的应用
CA3111878A1 (en) * 2018-09-07 2020-03-12 Merck Patent Gmbh 5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives
JP7433403B1 (ja) 2022-12-06 2024-02-19 本田技研工業株式会社 内燃機関及び鞍乗型車両

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005089352A (ja) 2003-09-16 2005-04-07 Kissei Pharmaceut Co Ltd 新規なイミダゾ[1,5−a]ピラジン誘導体、それを含有する医薬組成物およびそれらの用途
CN101468988A (zh) * 2007-12-26 2009-07-01 上海恒瑞医药有限公司 哌嗪类衍生物,其制备方法及其在医药上的应用
US9073927B2 (en) 2010-01-22 2015-07-07 Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii Inhibitors of PI3 kinase
CN104169284B (zh) * 2012-03-28 2017-03-29 默克专利股份公司 双环吡嗪酮衍生物
AU2013257018B2 (en) * 2012-05-04 2017-02-16 Merck Patent Gmbh Pyrrolotriazinone derivatives

Also Published As

Publication number Publication date
US9718826B2 (en) 2017-08-01
MX2016008042A (es) 2016-09-16
US20170002010A1 (en) 2017-01-05
KR20160101188A (ko) 2016-08-24
SI3087076T1 (en) 2018-01-31
HRP20171783T1 (hr) 2017-12-29
RU2016130148A3 (sr) 2018-07-25
DK3087076T3 (da) 2017-11-13
ES2654403T3 (es) 2018-02-13
RU2016130148A (ru) 2018-01-30
JP6446461B2 (ja) 2018-12-26
JP2017500353A (ja) 2017-01-05
CN105829317B (zh) 2019-03-29
AU2014372896A1 (en) 2016-08-04
HUE037606T2 (hu) 2018-09-28
WO2015096884A1 (en) 2015-07-02
AU2014372896B2 (en) 2018-08-16
TWI637956B (zh) 2018-10-11
NO3087076T3 (sr) 2018-02-24
PL3087076T3 (pl) 2018-01-31
CN105829317A (zh) 2016-08-03
MX364859B (es) 2019-05-09
EP3087076A1 (en) 2016-11-02
EP3087076B1 (en) 2017-09-27
CA2934663A1 (en) 2015-07-02
PT3087076T (pt) 2018-01-03
TW201605862A (zh) 2016-02-16
LT3087076T (lt) 2017-12-27
RU2672885C2 (ru) 2018-11-20
IL246406A0 (en) 2016-08-31
SG11201605189YA (en) 2016-07-28

Similar Documents

Publication Publication Date Title
HK1215795A1 (zh) 鵝膏毒素衍生物
SG11201506100XA (en) Pyridazinone-amides derivatives
ZA201601333B (en) Oxoquinazolinyl-butanamide derivatives
SG11201605189YA (en) Imidazopyrazinone derivatives
AU353576S (en) Stamphousing
HK1213566A1 (zh) 新的四唑酮衍生物
EP3009444A4 (en) ALPHA-oxoacyl-Amino-caprolactam derivative
AU4899P (en) Herbie53 Iresine herbstii
AU353326S (en) Kettlebell
AU353331S (en) Kettlebell
AU353330S (en) Kettlebell
AU353329S (en) Kettlebell
AU353328S (en) Kettlebell
AU353325S (en) Kettlebell
AU353327S (en) Kettlebell
AP00812S1 (en) Stumbelbloc
AU2013231V (en) Bonsca7200 Scaevola aemula
AU353341S (en) Playsuit
AU354283S (en) Playsuit
AP2013000704S (en) Gramoquat
AP2013000703S (en) Adwura wura
AP2013000606S (en) Loftank
AP2013000597S (en) Blueflame bioslurrigaz
AP2013000605S (en) Aquatank
AP2013000596S (en) Kentank